Daito Pharmaceutical Co.,Ltd.'s latest marketcap:
As of 06/23/2025, Daito Pharmaceutical Co.,Ltd.'s market capitalization has reached $204.2 M. According to our data, Daito Pharmaceutical Co.,Ltd. is the 19796th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 204.2 M |
| Revenue (ttm) | 334.27 M |
| Net Income (ttm) | 14.87 M |
| Shares Out | 29.99 M |
| EPS (ttm) | 0.49 |
| Forward PE | 15.31 |
| Ex-Dividend Date | 05/29/2025 |
| Earnings Date | 07/11/2025 |
Daito Pharmaceutical Co.,Ltd.'s yearly market capitalization.
| Date | Market Cap | Change (%) | Global Rank |
|---|---|---|---|
| 06/23/2025 | ¥204.2 M | -5.62% | 19796 |
| 12/30/2024 | ¥31.96 B | 6.17% | 18895 |
| 12/29/2023 | ¥30.1 B | -16.31% | 18424 |
| 12/30/2022 | ¥35.97 B | -12.37% | 16130 |
| 12/30/2021 | ¥41.05 B | -19.54% | 15455 |
| 12/30/2020 | ¥51.01 B | 26.75% | 11654 |
| 12/30/2019 | ¥40.25 B | 7.46% | 11573 |
| 12/28/2018 | ¥37.45 B | -6.18% | 11074 |
| 12/29/2017 | ¥39.92 B | 41.52% | 12110 |
| 12/30/2016 | ¥28.21 B | -35.51% | 12056 |
Company Profile
About Daito Pharmaceutical Co., Ltd.
Daito Pharmaceutical Co., Ltd. is a global pharmaceutical company specializing in the manufacturing and distribution of a diverse range of medical products.
Key Offerings
- Generic Drugs: High-quality, cost-effective alternatives to brand-name medications.
- Active Pharmaceutical Ingredients (APIs): Essential components for drug formulations.
- Over-the-Counter (OTC) Drugs: Accessible medications for common health needs.
- Contract Manufacturing: Specialized services for formulations, high-potent drugs, and packaging solutions.
Company Background
Originally established as Daito Corporation in 1942, the company rebranded to Daito Pharmaceutical Co., Ltd. in 1992 to reflect its core focus on pharmaceuticals. Headquartered in Toyama, Japan, the company has built a strong reputation in the global pharmaceutical industry.
Frequently Asked Questions
-
What is Daito Pharmaceutical Co.,Ltd.'s (TYO-4577) current market cap?As of 06/23/2025, Daito Pharmaceutical Co.,Ltd. (including the parent company, if applicable) has an estimated market capitalization of $204.2 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Daito Pharmaceutical Co.,Ltd. (TYO-4577) rank globally by market cap?Daito Pharmaceutical Co.,Ltd. global market capitalization ranking is approximately 19796 as of 06/23/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.